Clinical Trial Details


Research Study Summary

A Phase 3, Multi-site, randomized, mixed-blind, parallel-group treatment withdrawl and re-treatment study of the efficacy and safety of 2 oral doses of CP-690,550 in Subjects with Moderate to Severe Chronic Plaque Psoriasis


Patient Inclusion Criteria:

  • 18+ years of age
  • Diagnosis of stable plaque psoriasis
  • Moderate to severe
  • Covering at least 10% of total body surface area

Patient Exclusion Criteria:

  • Currently have non-plaque forms of psoriasis, eg, erythrodermic, guttate, or pustular psoriasis

To Learn more

CW ID: 169613
Date Last Changed: July 23, 2013

Clinical Trial Snapshot

Both Male and Female
18 and up
Overall Status
Facility Type


Dermatology Specialists, Inc.
3629 Vista Way
Oceanside, CA 92056
Phone: 760-757-7546

View Map

Research Center Information:

Dermatology Specialists, Inc.

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.